 |
| |
|
|
| |
| Products Name: |
Injection Grade Sodium Hyaluronate |
| Products Detail:: |
|
Items |
Specifications |
|
Appearance |
White Powder |
|
Solubility |
100% soluble in water |
|
Odour |
Characteristic |
|
Taste |
Characteristic |
|
Identification |
Positive |
|
Identification of Sodium |
Positive |
|
Sodium Hyaluronate |
95%-105% |
|
Glucuronic Acid |
Min.46% |
|
Appearance of Solution |
Clear Solution |
|
Transparency |
99.9% |
|
Molecule Weight (Dalton) |
−3.0 x 106 |
|
Intrinsic Viscosity |
Min.3.0 m3 /kg |
|
Ph |
5.0-8.5 |
|
Protein |
Max.0.1% |
|
Nucleic Acid |
Max.0.5% |
|
Chlorides |
Max.0.5% |
|
Loss on drying |
Max.10% |
|
Residual Isopropanol |
Max.0.5% |
|
Heavy Metal |
Max.10ppm |
|
Iron |
Max.80ppm |
|
Total plate count |
Max.10cfu/g |
|
E.Coli |
Negative |
|
Salmonella |
Negative |
|
Bacterial Endotoxin |
Max.0.05IU/mg |
|
Sterle Test |
Complies |
|
Items |
Specifications |
|
Appearance |
White Powder |
|
Solubility |
100% soluble in water |
|
Odour |
Characteristic |
|
Taste |
Characteristic |
|
Identification |
Positive |
|
Identification of Sodium |
Positive |
|
Sodium Hyaluronate |
95%-105% |
|
Glucuronic Acid |
Min.46% |
|
Appearance of Solution |
Clear Solution |
|
Transparency |
99.9% |
|
Molecule Weight (Dalton) |
−3.0 x 106 |
|
Intrinsic Viscosity |
Min.3.0 m3 /kg |
|
Ph |
5.0-8.5 |
|
Protein |
Max.0.1% |
|
Nucleic Acid |
Max.0.5% |
|
Chlorides |
Max.0.5% |
|
Loss on drying |
Max.10% |
|
Residual Isopropanol |
Max.0.5% |
|
Heavy Metal |
Max.10ppm |
|
Iron |
Max.80ppm |
|
Total plate count |
Max.10cfu/g |
|
E.Coli |
Negative |
|
Salmonella |
Negative |
|
Bacterial Endotoxin |
Max.0.05IU/mg |
|
Sterle Test |
Complies | |
| Key Words: |
Cataract Surgery. Glaucoma Surgery. Corneal transplant surgery. Retinal attachment surgery. Skin filler. Anti-wrinkle. Arthrosis-Injection
|
|
|
|
| |
|
|
 |
|
|
|
|
| |
 |
|
| |
Our goal is to combine high quality products with good services and appropriate prices. And we think we have achieved that goal. To get Focuschem please contact us directly. See us´´ |
|
|
|
